Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
Q&A: Advantages of NADAC for Stakeholders in the Drug Supply Chain
Drug Topics November 13, 2024
A conversation with AJ Loiacono, co-founder and CEO of Capital RX, at NCPA 2024.
The National Average Drug Acquisition Cost (NADAC) is a benchmark that provides drug prices to the pharmaceutical supply chain. The prices, which are determined by averaging prices from retail community pharmacies across the United States, are gathered from the monthly Retail Price Survey conducted by the Centers for Medicare and Medicaid Services (CMS). NADAC aims to provide more accurate drug prices for states who use it as a reference price when setting their reimbursement methodology.
At the National Community Pharmacists Association (NCPA) 2024 Annual Convention and Expo, held October 26 to 29 in Columbus, Ohio, Drug Topics sat down with AJ Loiacono, co-founder and CEO of...
Today's Sponsors
Today's Sponsor